Abstract
Convulsions of E1 mice were completely suppressed by 60 mg/kg of piperine injected intraperitoneally. The ED50 was 21.1 mg/kg. The brain 5-HT, dopamine and norepinephrine levels were estimated 1 hour after the intraperitoneal injection of piperine. The 5-HT level was significantly higher in the cerebral cortex of piperine treated mice than in control mice. This increase may be related directly to the mechanism of inhibition of convulsions by piperine. On the other hand, lower levels of 5-HT were observed in the hippocampus, midbrain and cerebellum. The dopamine level in the piperine treated mice was markedly higher only in the hypothalamus, while the norepinephrine levels were lower in every part of the brain.
Similar content being viewed by others
References
Pei, Y. Q., andTao, C. 1974. The anticonvulsant and sedative action of piperine. J. Beijing Med. College 4:217–220.
Pei, Y. Q. 1983. Arevien of pharmacology and clinical use of piperine and its derivatives. Epilepsia 24:177–182.
Imaizumi, K., Ito, S., Kutukake, G., Takayasu, T., Fujiwara, K., andTutikawa, K. 1959. The epilepsy-like abnormalities in a strain of mouse. Jikken-Dobutsu (Exp. Anim.) 8:6–10.
Hiramatsu, M. 1983. Brain 5-hydroxytryptamine level, metabolism, and binding in E1 mice. Neurochem. Res. 8:1163–1175.
Westerink, B. H. C., andMulder, T. B. A. 1981. Determination of picomole amounts of dopamine, noradrenaline, 3,4-dihydroxy-phenylalanine, 3,4-dihydroxyphenylacetic acid, homovanillic acid, and 5-hydroxyindolacetic acid in nervous tissue after one-step purification of Sephadex G-10, using high-performance liquid chromatography with a novel type of electrochemical detection. J. Neurochem. 36:1449–1462.
Azzaro, A. J., Wenger, G. R., Craig, C. R., andStitzel, R. E. 1972. Reserpine-induced alterations in brain amines and their relationship to changes in the incidence of minimal electroshock seizures in mice. J. Pharmacol. Exp. Ther. 180:558–568.
Kilian, M., andFrey, H. 1973. Central monoamines and convulsive thresholds in mice and rats. Neuropharmacology 12:681–692.
Nasello, A. G., andMarichich, E. S. 1973. Effects of some cholinergic, adrenergic and serotonergic compounds, glutamic acid and GABA on hippocampal seizures. Pharmacology 9:233–239.
Wenger, G. R., Stitzel, R. E., andCraig, C. R. 1973. The role of biogenic amines in the reserpine-induced alteration of minimal electroshock seizure thresholds in the mouse. Neuropharmacology 12:693–703.
Alexander, G. J., andKopeloff, L. M. 1970. Metrazol seizures in rats: effects of p-chlorophenylalanine. Brain Res. 22:231–235.
Browning, R. A., Hoffmann, W. E., andSimonton, L. 1978. Changes in seizure susceptibility after intracerebral treatment with 5,7-dihydroxytryptamine: role of serotonergic neurones. Ann. N.Y. Acad. Sci. 305:437–456.
De La Torre, J. C., Kawanaga, H. M., andMullan, S. 1970. Seizure susceptibility after manipulation of brain serotonin. Arch. Int. Pharmacodyn. 188:298–304.
De La Torre, J. C., andMullan, S. 1970. A possible role for 5-hydroxytryptamine in drug-induced seizures. J. Pharm. Pharmacol. 22:858–859.
Munkenbeck, K. E., andSchwark, W. S. 1982. Serotonergic mechanisms in amygdaloidkindled seizures in the rat. Exp. Neurol. 76:246–253.
Jobe, P. C., Picchioni, A., andChin, L. 1973. Role of brain 5-hydroxytryptamine in audiogenic seizures in the rat. Life Sci. 13:1–13.
Lints, C. E., Willott, J. E., Sze, P. Y., andNenja, L. H. 1980. Inverse relationship between whole brain monoamine levels and audiogenic seizure susceptibility in mice. Pharmacol. Biochem. Behav. 12:385–388.
Nellhaus, G. 1968. Relationship of brain serotonin to convulsions. Neurology 18:298–299.
Screiber, R. A., andSchlesinger, K. 1971. Circadian rhythms and seizure susceptibility: relation to 5-hydroxytryptamine and norepinephrine in brain. Physiol. Behav. 6:635–640.
Schreiber, R. A., andSchlkesinger, K. 1972. Circadian rhythms and seizure susceptibility: effects of manipulations of light cycles on susceptibility to audiogenic sezzures and on levels of 5-hydroxytryptamine and norepinephrine in brain. Physiol. Behav. 8:699–703.
Sparks, D. L., andBuckholtz, N. S. 1980. Effects of 6-methoxy-1,2,3,4-tetrahydro-β-carboline (6-MeO-THβC) on audiogenic seizures in DBA/2J mice. Pharmacol. Biochem. Behav. 12:119–124.
Truscott, T. C. 1975. Effects of phenylalanine and 5-hydroxytryptophan on seizure severity in mice. Pharmacol. Biochem. Behav. 3:939–941.
Wada, J. A., Balzammo, E., Meldrum, B. S., andNaquet, R. 1972. Behavioural and electrographic effects of L-5-hydroxytryptophan and D,L-parachlorophenylalanine on epileptic senegalese baboon (papio papio). Electroencephalogr. Clin. Neurophysiol. 33:520–526.
Kobayashi, K., andMori, A. 1977. Brain monoamines in seizure mechanism (Review). Folia Psychiatr. Neurol. Jpn. 31:483–489.
Hiramatsu, M. 1981. Brain monoamine levels and E1 mouse convulsions. Folia Psychiatr. Neurol. Jpn. 35:261–266.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mori, A., Kabuto, H. & Pei, YQ. Effects of piperine on convulsions and on brain serotonin and catecholamine levels in E1 mice. Neurochem Res 10, 1269–1275 (1985). https://doi.org/10.1007/BF00964845
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00964845